Trial Profile
Phase I Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jun 2018
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Ginseng
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 13 Jun 2018 Status changed from active, no longer recruiting to completed.
- 09 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.